SEPTInvestingStart Free

SBFM SCHEDULE 13G/A: SEC filing

Filed with the SEC on · accession 0001213900-26-118164

SBFM filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 10, 2026. Intracoastal Capital LLC, along with Mitchell P. The stock moved +1.1% by the first close after the filing.

Summary of the filing

Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, filed an amended Schedule 13G reporting beneficial ownership of approximately 9.99% of Sunshine Biopharma's common stock, represented by 430,336 shares issuable upon exercise of a warrant subject to a 9.99% blocker provision.

For details, click here →

Key details

Shares of common stock issuable upon exercise of Intracoastal Warrant 1 (subject to 9.99% blocker)$430K
Total shares beneficially owned without blocker provisions$4.3M
Reporting person / warrant holderIntracoastal Capital LLC
IssuerSunshine Biopharma Inc.
Reporting person / manager of intracoastal capital llcMitchell P. Kopin
Reporting personDaniel B. Asher

How SBFM stock reacted

Close before

$2.75

Nov 9, 2026

First close after

+1.09%

$2.78

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for SBFM, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for SBFM?

Click here

Frequently asked questions

What did SBFM file with the SEC on Nov 10, 2026?

SBFM filed a SCHEDULE 13G/A (SEC filing). Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, filed an amended Schedule 13G reporting beneficial ownership of approximately 9.99% of Sunshine Biopharma's common stock, represented by 430,336 shares issuable upon exercise of a warrant subject to a 9.99% blocker provision.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did SBFM stock react to this filing?

SBFM closed at $2.75 before the filing and $2.78 on Nov 10, 2026 (+1.09%).

Other SBFM SEC filings

Get alerts when SBFM files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
SBFM overviewSBFM analysisSBFM newsLatest SEC filings